Video

Juanita Madison on Handling the Provenge Process

Author(s):

Juanita Madison, MN, RN

In Partnership With:

Juanita Madison from the Seattle Cancer Care Alliance on Handling the Provenge Treatment Process

Lead researcher Juanita Madison, MN, RN, AOCN from the Seattle Cancer Care Alliance (SCCA) of a multidisciplinary study looking at Provenge discusses handling the treatment process. Using the Plan-Do-Study-Act quality-improvement model the multidisciplinary task-force devised, implemented, and revised a Provenge treatment strategy.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All
Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma
Multimedia

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

May 15th 2025 - May 16th 2026

online-activity
View More
Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer
Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

May 15th 2025 - May 16th 2026

online-activity
View More
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

May 14th 2025 - Jun 19th 2025

online-activity
View More
Related Content
Solid tumors | Image Credit: © Kellie Ehrmann/MJH Life Sciences Using AI
May 15th 2025

Pembrolizumab-Based Regimen Yields PFS Benefit in Platinum-Resistant Ovarian Cancer

Ryan Cassaday, MD, associate professor, Clinical Research Division, Fred Hutchinson Cancer Center; associate professor, Division of Hematology and Oncology, University of Washington School of Medicine
January 23rd 2025

Blinatumomab-Based Regimens Enhance and Refine the B-ALL Treatment Paradigm: With Ryan Cassaday, MD

Image Credit: © catalin – stock.adobe.com
May 13th 2025

Frontline Belrestotug Plus Dostarlimab Misses PFS End Point in PD-L1–High NSCLC

Mazyar Shadman, MD, MPH, associate professor, Clinical Research Division, medical director, Cellular Immunotherapy, Fred Hutchinson Cancer Center
December 19th 2024

Zanubrutinib Leads the Way for Advancements in CLL Management: With Mazyar Shadman, MD, MPH

The top 5 OncLive videos of the week cover insights in myelodysplastic syndrome, lung cancer, hepatocellular carcinoma, colorectal cancer, and ovarian cancer.
May 11th 2025

Five Under 5: Top Oncology Videos for the Week of 5/4

Illuccix PSMA-PET Imaging in Prostate Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
May 9th 2025

Illuccix PSMA-PET Imaging Kit Earns Czech Marketing Authorization in Prostate Cancer